The paradigm for cancer diagnostics has shifted. Large scale genomic profiling of a tumor and then sending a patient down a treatment track has become commonplace and sequencing technology is no longer a main bottleneck. Cambridge Healthtech Institute’s Inaugural Cancer Sequencing conference will focus on the newer pain point in cancer diagnostics – analyzing and making data actionable. At this event, the field’s foremost experts will come together to discuss creative ways to distribute and explore next-generation sequencing (NGS) data. The disconnect between uncovering therapeutic targets and a lack of drugs will also be explored. This meeting will send attendees back to their organizations with ideas and solutions to move their cancer sequencing programs into the clinic.#
For more information, click here